Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
More News related to ACAD
- Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
- ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results
- ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
- ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009
- ACADIA Pharma (ACAD) to Cut Workforce by 50%
Acadia Pharmaceuticals Inc. (NYSE: ACAD) reports a Q3 loss of $0.23, 1 cent better than the analyst estimate of ($0.24). Revenue for the quarter was $2.4 million, which compares to the estimate of $2 million.
Related Categories
EarningsStocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
